IP Addendum-2015 to IP-2014 has been released on 28.11.2014 by Sh. Lov Verma, Secretary Health & Family Welfare and Chairman, India Pharmacopoeia Commission in the presence of senior officers of Ministry of Health & Family Welfare and Scientific Staff of IP Commission.
The Addendum 2015 of the Indian Pharmacopoeia 2014 is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Government of India, Ministry of Health & Family Welfare. The Indian Pharmacopoeia (IP) is published in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules thereunder. It prescribes the standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines. The standards of this pharmacopoeia are authoritative and legally enforceable. It intends to help in the licensing of manufacturing, inspection and distribution of medicines.
IP and its Addendum are published in continuing pursuit of the mission of IPC to improve the health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant inputs from regulatory, industrial houses, academic institutions, national laboratories, individual scientists and others. Publication of IP at regular and shorter intervals is one of the main mandates of the Commission.
The Addendum is published in accordance with the principles and designed plan decided by the Scientific Body of the IPC. To establish transparency in setting standards for this edition, the contents of new monographs, revised appendices and other informations have been publicized on the website of the IPC, besides following conventional approach of obtaining comments. The feedback and inputs were reviewed by the relevant Expert Committee to ensure the feasibility and practicability of the standards and methods revised. The principle of “openness, justice and fairness" is kept in mind during compiling and editing the contents of this edition.
This Addendum has the same authority as the Indian Pharmacopoeia 2014. The General Notices, Monographs, Appendices and other contents of the Indian Pharmacopoeia that are amended by this Addendum supersede the original matter. This Addendum amends as well as adds new materials to the Indian Pharmacopoeia 2014. The General Notices and Appendices included in the Indian Pharmacopoeia 2014 apply to the contents of this Addendum as well unless specifically stated otherwise.
Addendum 2015 to IP 2014 incorporates 82 new monographs consisting of 57 Chemical monographs, 13 Herbal monographs, 2 Human Vaccines monographs and 10 Radiopharmaceutical monographs etc. It is hoped that this addendum would play a significant role in improving the quality of medicines which in turn promote public health and accelerate the growth and development of Pharma Sector.
